The natural course of non-alcoholic fatty liver disease

L Calzadilla Bertot, LA Adams - International journal of molecular …, 2016 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease
in the world, paralleling the epidemic of obesity and Type 2 diabetes mellitus (T2DM) …

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

European Association for the Study of the Liver (EASL)… - Obesity Facts, 2024 - karger.com
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …

[HTML][HTML] Changes in nutritional status after liver transplantation

M Giusto, B Lattanzi, V Di Gregorio… - World journal of …, 2014 - ncbi.nlm.nih.gov
Chronic liver disease has an important effect on nutritional status, and malnourishment is
almost universally present in patients with end-stage liver disease who undergo liver …

[HTML][HTML] Nutrition therapy: Integral part of liver transplant care

LR Anastacio, MITD Correia - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Managing malnutrition before liver transplantation (LTx) while on the waiting list and,
excessive weight gain/metabolic disturbances in post-surgery are still a challenge in LTx …

Metabolic consequences of solid organ transplantation

M Bhat, SE Usmani, A Azhie, M Woo - Endocrine Reviews, 2021 - academic.oup.com
Metabolic complications affect over 50% of solid organ transplant recipients. These include
posttransplant diabetes, nonalcoholic fatty liver disease, dyslipidemia, and obesity …

[HTML][HTML] Management of diabetes in candidates for liver transplantation and in transplant recipients

L Brodosi, S Petta, ML Petroni, G Marchesini… - …, 2022 - journals.lww.com
Diabetes is common in patients waitlisted for liver transplantation because of end-stage liver
disease or hepatocellular cancer as well as in posttransplant phase (posttransplantation …

[HTML][HTML] EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

F Tacke, P Horn, VWS Wong, V Ratziu, E Bugianesi… - Journal of …, 2024 - Elsevier
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …

Management of diabetes mellitus in patients undergoing liver transplantation

V Grancini, V Resi, E Palmieri, G Pugliese… - Pharmacological …, 2019 - Elsevier
Diabetes is a common feature in cirrhotic individuals both before and after liver
transplantation and negatively affects prognosis. Certain aetiological agents of chronic liver …

Prospective evaluation of metabolic syndrome and its components among long‐term liver recipients

LR Anastácio, KG Diniz, HS Ribeiro… - Liver …, 2014 - Wiley Online Library
Abstract Background & Aims Survival after liver transplantation (LT x) has increased.
Metabolic syndrome (MS) is widely reported in patients in the early years after LT x; few …

High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter

LY Mak, ACY Chan, TCL Wong, WC Dai, WH She… - BMC …, 2023 - Springer
Abstract Background & Aims Although non-alcoholic fatty liver disease (NAFLD) remains an
uncommon indication for liver transplantation (LT) in the Chinese, the prevalence of NAFLD …